SCHEMBL7635112

SCHEMBL7635112

C=C(c1ccc(C)cc1)c1ccccc1O[Si](C)(C)CCCC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.35
ABCB1 P08183 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CYP3A4 P08684 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
RECQL P46063 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NR1I2 O75469 1/20 0.32
LMNA P02545 1/20 0.32
CHRM2 P08172 1/20 0.32
ADRA2A P08913 1/20 0.32
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7636442 0.80
SCHEMBL7632092 0.79 GABRA1 (0.31)
SCHEMBL3125917 0.75 KDM4E (0.56) L3MBTL1MAPTALDH1A1MEN1KMT2A
SCHEMBL10385495 0.74 LMNA (0.41) L3MBTL1MAPTALDH1A1MAPK1MEN1
Hydrochloric Acid SCHEMBL10385497 0.74 KDM4E (0.55) L3MBTL1MAPTALDH1A1MEN1KMT2A
SCHEMBL5074488 0.71 CA1 (0.42) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL10584058 0.69 ACHE (0.37) RAB9AL3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL18304615 0.69 ENPP2 (0.46) MAPTMEN1KMT2ACYP3A4CYP1A2
SCHEMBL16417118 0.68 CYP1A2 (0.56) MAPTALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6585052 0.68 MEN1 (0.40) RAB9AL3MBTL1MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0975573-B1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES INC (US) 2002-09-18 EP disclosed